But the results add to evidence from animal studies and reports that people are finding drugs like Ozempic and Wegovy helpful ...
Semaglutide, the drug sold as Ozempic to treat type 2 diabetes and Wegovy for weight loss, reduced alcohol cravings and ...
A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.
In a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an ...
Novo Nordisk ( NVO -2.98%) stock is in a funk. Shares of the GLP-1 diet drug manufacturer have been sliding all week long, ...
Aardvark Therapeutics has followed up filings and speculation with a $94 million initial public offering, putting itself on ...
Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.
Hosted on MSN8h
LLY Rises More Than 4% in a Week: How to Play the StockEli Lilly and Company’s LLY shares have risen 4.3% since it reported fourth-quarter results on Feb. 6. Lilly’s fourth-quarter ...
Recent studies reveal a concerning trend of vision loss among patients using Ozempic and other weight loss products, raising questions about their safety.
Cardiologists believe Ozempic and Wegovy could help prevent heart disease. Dr. Marc Gibber, medical director and chief of cardiothoracic surgery at Baptist Health Bethesda Hospital East, stopped by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback